
If you're about to file an R&D claim — or you're bracing for a possible HMRC R&D enquiry — it's worth knowing that the team reviewing R&D claims has changed. In March 2026, HMRC confirmed it is winding down the "volume compliance" approach run by its Individuals and Small Business Compliance (ISBC) unit and moving R&D enquiry work back into its Wealthy and Mid-sized Business Compliance (WMBC) directorate. It's a quiet administrative change with real consequences for how new claims get reviewed.
Here's what has changed, why it matters, and how to be ready.
Since 2022, most R&D enquiries were handled by ISBC under a "volume compliance" model — high numbers of standardised checks, largely run through templated letters. HMRC has now announced it is ending that approach. Over roughly the following six months, ISBC officers are being redeployed, and R&D compliance is being consolidated within WMBC.
In practice this reinstates the pre-2022 position, when WMBC handled R&D enquiries and the focus was on more complex or higher-risk cases rather than sheer volume. HMRC's own practice note for how officers should review claims — CIRD80525 — now applies to officers in both ISBC and WMBC.
The volume approach was a response to a well-documented problem. HMRC told the House of Commons Public Accounts Committee that it had moved to checking around one in five R&D claims — up from a historic enquiry rate of roughly 1% — after estimating that error and fraud accounted for a significant share of the relief paid out. You can read HMRC's rationale in its published approach to Research and Development tax reliefs.
The volume model was effective at raising the enquiry rate, but widely criticised — including by the tax profession — for catching legitimate claims in templated challenges and for being difficult to engage with. Moving the work to WMBC signals a shift back towards more targeted scrutiny of genuinely complex risks.
For claimants, the change of team usually means a change of tone. WMBC has historically run enquiries on a more individual basis:
That is generally good news if your claim is well-evidenced and you can explain the technology. It can be tougher if the underlying claim is thin, because a named officer engaging in detail is harder to satisfy with boilerplate answers.
The fundamentals of surviving an HMRC compliance check haven't changed — but the move to WMBC raises the premium on being able to defend the substance of your claim in a conversation, not just on paper.
Going forward, R&D enquiry work is being resourced through WMBC — so a claim you file now is more likely to be reviewed by a named caseworker taking a more engaged, technically-focused approach. Either way, the discipline is the same: answer the standing questions on their merits, not with boilerplate. For what may change next, see our preview of the Autumn Budget 2026 and R&D tax relief.
HMRC announced in March 2026 that it is winding down ISBC's volume-compliance approach to R&D and consolidating R&D compliance within its WMBC directorate over roughly the following six months, with ISBC officers being redeployed. The change is about how HMRC resources new enquiry work rather than a promise about any individual open case.
WMBC is HMRC's Wealthy and Mid-sized Business Compliance directorate. It handled R&D enquiries before 2022 and tends to run cases with a named caseworker and direct engagement, focusing on more complex risks rather than high-volume templated checks.
Not necessarily. HMRC has been checking around one in five R&D claims. The change is about who runs the enquiry and how, not a signal that scrutiny is easing — a well-evidenced claim remains the best protection.
Don't reply off the cuff. Gather your contemporaneous evidence, reconcile your figures, and consider specialist R&D tax relief enquiry support before you respond — early framing of the technical case matters more under a named caseworker.

HMRC’s R&D tax credit statistics 2026 show SME claims down 19% even as total relief rises — what’s behind the fall and what it means for your claim.

How does the Patent Box work? A plain-English guide to the 10% Corporation Tax rate on patent profits — eligibility, the development condition, the R&D nexus, how to elect, and a worked example.

The Chancellor will deliver the Autumn Budget 2026 on Wednesday 28 October. For any UK company running an R&D tax relief claim — or planning its first — it is worth knowing what is genuinely on the table before the red box opens, and what is simply noise. The short version: after three years of near-constant reform, the R&D regime is finally settling. Most of what matters for your next claim is already law. But a Budget always carries the risk of a technical tweak, and there are a few signals worth tracking. Where the R&D rules stand going into the Budget The big structural change is done. The merged RDEC scheme is now the default for accounting periods beginning on or after 1 April 2024, replacing the old separate SME and RDEC regimes. It gives a taxable expenditure credit of 20% of qualifying R&D costs — worth roughly 15% net once Corporation Tax at 25% is applied. Loss-making, R&D-intensive SMEs are the exception. If your qualifying R&D is at least 30% of total expenditure, you may instead claim under Enhanced R&D Intensive Support (ERIS), which offers a more generous deduction and a payable credit for surrenderable losses. None of […]